Nordicus Partners Corp Files 8-K
Ticker: NORD · Form: 8-K · Filed: Jan 2, 2025 · CIK: 1011060
Sentiment: neutral
Topics: 8-K, filing, disclosure
TL;DR
Nordicus Partners Corp filed an 8-K, mostly routine stuff, check financials.
AI Summary
Nordicus Partners Corp. filed an 8-K on January 2, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC, is incorporated in Delaware and its fiscal year ends on March 31st. The filing does not contain specific financial figures or event details beyond its classification.
Why It Matters
This filing indicates a routine disclosure or submission of financial documents by Nordicus Partners Corp. to the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — The filing appears to be a standard 8-K for disclosures and exhibits without immediate negative or positive financial implications mentioned.
Key Players & Entities
- Nordicus Partners Corp (company) — Registrant
- EKIMAS Corp (company) — Former Company Name
- AdvanSource Biomaterials Corp (company) — Former Company Name
- CARDIOTECH INTERNATIONAL INC (company) — Former Company Name
- Delaware (jurisdiction) — State of Incorporation
- January 2, 2025 (date) — Date of Report
FAQ
What specific event triggered this 8-K filing?
The filing is classified under 'Regulation FD Disclosure' and 'Financial Statements and Exhibits', but the specific triggering event is not detailed in the provided text.
What is the primary business of Nordicus Partners Corp?
Nordicus Partners Corp. is classified under 'SERVICES-MANAGEMENT CONSULTING SERVICES [8742]'.
When does Nordicus Partners Corp.'s fiscal year end?
The company's fiscal year ends on March 31st.
What were Nordicus Partners Corp.'s previous names?
The company was formerly known as EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC.
Where is Nordicus Partners Corp. headquartered?
The company's business address is 280 South Beverly Dr., Suite 505, Beverly Hills, CA 90212.
Filing Stats: 665 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2025-01-02 16:08:13
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 18KB
- ex99-1_001.jpg (GRAPHIC) — 133KB
- ex99-1_002.jpg (GRAPHIC) — 177KB
- ex99-1_003.jpg (GRAPHIC) — 154KB
- ex99-1_004.jpg (GRAPHIC) — 67KB
- ex99-1_005.jpg (GRAPHIC) — 103KB
- ex99-1_006.jpg (GRAPHIC) — 149KB
- ex99-1_007.jpg (GRAPHIC) — 150KB
- ex99-1_008.jpg (GRAPHIC) — 100KB
- ex99-1_009.jpg (GRAPHIC) — 92KB
- ex99-1_010.jpg (GRAPHIC) — 131KB
- ex99-1_011.jpg (GRAPHIC) — 135KB
- ex99-1_012.jpg (GRAPHIC) — 86KB
- ex99-1_013.jpg (GRAPHIC) — 141KB
- ex99-1_014.jpg (GRAPHIC) — 121KB
- ex99-1_015.jpg (GRAPHIC) — 163KB
- ex99-1_016.jpg (GRAPHIC) — 116KB
- ex99-1_017.jpg (GRAPHIC) — 119KB
- ex99-1_018.jpg (GRAPHIC) — 124KB
- ex99-1_019.jpg (GRAPHIC) — 118KB
- ex99-1_020.jpg (GRAPHIC) — 122KB
- ex99-1_021.jpg (GRAPHIC) — 163KB
- 0001493152-25-000059.txt ( ) — 3926KB
- nord-20250102.xsd (EX-101.SCH) — 3KB
- nord-20250102_def.xml (EX-101.DEF) — 29KB
- nord-20250102_lab.xml (EX-101.LAB) — 33KB
- nord-20250102_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: January 2, 2025 Nordicus Partners Corporation By: /s/ Henrik Rouf Henrik Rouf Chief Executive Officer